Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Giannetti

Showing results (41-50 of 63) with videos related to

Pageof 7
Sort By:
Journal of Medicinal Chemistry|March 29, 2011
Identification, characterization, and implications of species-dependent plasma protein binding for the oral Hedgehog pathway inhibitor vismodegib (GDC-0449)Anthony M Giannetti, Harvey Wong, Gerrit J P Dijkgraaf, et al.
International Journal of Obesity (2005)|December 7, 2011
Hepatic left lobe volume is a sensitive index of metabolic improvement in obese women after gastric bandingM Giannetti, P Piaggi, G Ceccarini, et al.
Lancet (London, England)|July 30, 2017
Recombinant human C1 esterase inhibitor for prophylaxis of hereditary angio-oedema: a phase 2, multicentre, randomised, double-blind, placebo-controlled crossover trialMarc A Riedl, Vesna Grivcheva-Panovska, Dumitru Moldovan, et al.
Cancer Cell|August 27, 2014
Structure of the BRAF-MEK complex reveals a kinase activity independent role for BRAF in MAPK signalingJacob R Haling, Jawahar Sudhamsu, Ivana Yen, et al.
The Journal of Biological Chemistry|February 28, 2009
Slow binding inhibition and mechanism of resistance of non-nucleoside polymerase inhibitors of hepatitis C virusJulie Qi Hang, Yanli Yang, Seth F Harris, et al.
Journal of Virology|May 30, 2006
Selection and characterization of replicon variants dually resistant to thumb- and palm-binding nonnucleoside polymerase inhibitors of the hepatitis C virusSophie Le Pogam, Hyunsoon Kang, Seth F Harris, et al.
Science (New York, N.Y.)|October 25, 2011
Antagonists induce a conformational change in cIAP1 that promotes autoubiquitinationErin C Dueber, Allyn J Schoeffler, Andreas Lingel, et al.
Chemmedchem|November 22, 2013
Tailoring small molecules for an allosteric site on procaspase-6Jeremy Murray, Anthony M Giannetti, Micah Steffek, et al.
Bioorganic & Medicinal Chemistry Letters|August 21, 2014
Fragment-based identification and optimization of a class of potent pyrrolo[2,1-f][1,2,4]triazine MAP4K4 inhibitorsLan Wang, Mark Stanley, Jason W Boggs, et al.
Bioorganic & Medicinal Chemistry Letters|April 11, 2008
Fragment-based discovery of hepatitis C virus NS5b RNA polymerase inhibitorsStephen S Antonysamy, Brandon Aubol, Jeff Blaney, et al.
Pageof 7

Showing results (41-50 of 63) with videos related to

Sort By:
Pageof 7
Journal of Medicinal Chemistry|March 29, 2011
Identification, characterization, and implications of species-dependent plasma protein binding for the oral Hedgehog pathway inhibitor vismodegib (GDC-0449)Anthony M Giannetti, Harvey Wong, Gerrit J P Dijkgraaf, et al.
International Journal of Obesity (2005)|December 7, 2011
Hepatic left lobe volume is a sensitive index of metabolic improvement in obese women after gastric bandingM Giannetti, P Piaggi, G Ceccarini, et al.
Lancet (London, England)|July 30, 2017
Recombinant human C1 esterase inhibitor for prophylaxis of hereditary angio-oedema: a phase 2, multicentre, randomised, double-blind, placebo-controlled crossover trialMarc A Riedl, Vesna Grivcheva-Panovska, Dumitru Moldovan, et al.
Cancer Cell|August 27, 2014
Structure of the BRAF-MEK complex reveals a kinase activity independent role for BRAF in MAPK signalingJacob R Haling, Jawahar Sudhamsu, Ivana Yen, et al.
The Journal of Biological Chemistry|February 28, 2009
Slow binding inhibition and mechanism of resistance of non-nucleoside polymerase inhibitors of hepatitis C virusJulie Qi Hang, Yanli Yang, Seth F Harris, et al.
Journal of Virology|May 30, 2006
Selection and characterization of replicon variants dually resistant to thumb- and palm-binding nonnucleoside polymerase inhibitors of the hepatitis C virusSophie Le Pogam, Hyunsoon Kang, Seth F Harris, et al.
Science (New York, N.Y.)|October 25, 2011
Antagonists induce a conformational change in cIAP1 that promotes autoubiquitinationErin C Dueber, Allyn J Schoeffler, Andreas Lingel, et al.
Chemmedchem|November 22, 2013
Tailoring small molecules for an allosteric site on procaspase-6Jeremy Murray, Anthony M Giannetti, Micah Steffek, et al.
Bioorganic & Medicinal Chemistry Letters|August 21, 2014
Fragment-based identification and optimization of a class of potent pyrrolo[2,1-f][1,2,4]triazine MAP4K4 inhibitorsLan Wang, Mark Stanley, Jason W Boggs, et al.
Bioorganic & Medicinal Chemistry Letters|April 11, 2008
Fragment-based discovery of hepatitis C virus NS5b RNA polymerase inhibitorsStephen S Antonysamy, Brandon Aubol, Jeff Blaney, et al.
Pageof 7